1. Specific recruitment of CD4+CD25++regulatory T cells into the allograft in heart transplant recipients
- Author
-
Caroline Schmidt-Lucke, Sergio Romagnani, Björn Gareis, Alexandra Aicher, Andreas M. Zeiher, Paola Romagnani, and Stefanie Dimmeler
- Subjects
Male ,Pathology ,medicine.medical_specialty ,Adolescent ,Physiology ,medicine.medical_treatment ,chemical and pharmacologic phenomena ,Inflammation ,T-Lymphocytes, Regulatory ,Coronary circulation ,Physiology (medical) ,medicine ,Humans ,Transplantation, Homologous ,IL-2 receptor ,Child ,Cells, Cultured ,Heart transplantation ,business.industry ,Interleukin-2 Receptor alpha Subunit ,Infant ,T lymphocyte ,CD4 Lymphocyte Count ,Transplantation ,Cd4 cd25 ,medicine.anatomical_structure ,Child, Preschool ,CD4 Antigens ,Immunology ,Circulatory system ,Heart Transplantation ,Female ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business - Abstract
Regulatory T cells (Treg) migrate into allografts and induce tolerance of the graft. Immunosuppressive Tregare found among CD4+CD25++T cells and specifically express the forkhead/winged transcription factor FOXP3. We hypothesized that activated T cells and Tregmight modulate the ongoing inflammation of the cardiac allograft (CA) and that the chronic inflammatory environment might influence the balance between these distinct cell types. We therefore quantified levels of activated T cells and CD4+CD25++Tregin the cardiac and systemic circulation in heart transplant recipients. To determine the influence of the allograft passage on these cells, transcardiac gradients were evaluated in CA recipients ( n = 22) compared with controls ( n = 18). Systemic levels of circulating Tregwere significantly lower in CA recipients (8.9 ± 1.3 μl) compared with controls (15.8 ± 1.6 μl; P = 0.002). Similarly, the proportion of Tregrelated to the total leukocyte number was significantly lower in CA recipients ( P < 0.01). In contrast, systemic levels of circulating activated CD4+T cells and of circulating plasmacytoid dendritic cells were similar in both groups. In transplant patients, numbers of Tregsignificantly decreased during transcardiac passage (3.0 ± 0.3 to 2.4 ± 0.3% of CD4+T cells, P < 0.01), and FOXP3+T cells invaded into the allograft. In contrast, numbers of activated CD4+T cells increased during passage through the allograft, even in the presence of effective immunosuppression. In conclusion, numbers of circulating immunosuppressive Tregare reduced in transplant recipients. Recruitment of Treginto the cardiac allograft during transcoronary passage may induce graft tolerance during subclinical inflammation potentially influencing allograft vasculopathy.
- Published
- 2007